Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Novovich Serge
 2. Date of Event Requiring Statement (Month/Day/Year)
07/15/2014		 3. Issuer Name and Ticker or Trading Symbol
IRADIMED CORP [IRMD]
(Last)
(First)
(Middle)
C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR.		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

WINTER SPRINGS, FL 32708		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   (1) 11/18/2022 Common Stock 17,500 $ 1.29 D  
Stock Option (Right to Buy)   (2) 12/29/2023 Common Stock 26,250 $ 1.48 D  
Series A Convertible Preferred Stock 04/14/2014   (3) Common Stock 140,000 $ (3) I By Pacific Summit Capital LLC (4)

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Novovich Serge
C/O IRADIMED CORPORATION
1025 WILLA SPRINGS DR.
WINTER SPRINGS, FL 32708		   X      

Signatures

/s/ Serge Novovich 07/15/2014
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) This option was granted on 11/20/2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.
(2) This option was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.
(3) The Series A Convertible Preferred Stock is convertible into Iradimed Corporation Common Stock on a one-for-one basis and has no expiration date. The shares will automatically convert upon the closing of Iradimed Corporation's initial public offering if the aggregate amount of the offering is not less than $10,000,000.
(4) The reporting person is a manager of Pacific Summit Capital LLC and indirectly owns approximately 66.7% of Pacific Summit Capital LLC. The reporting person disclaims beneficial ownership of the shares held by Pacific Summit Capital LLC except to the extent of his pecuniary interest, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.